Stimulation of antibody formation and inhibition of 256 Walker carcinosarcoma development in rats treated with low-molecular-weight thymic polypeptides (TP2).
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D001428:Bacterial Vaccines / Q000494:pharmacology; D002279:Carcinoma 256, Walker / Q000276:immunology* / Q000628:therapy; D007252:Influenza Vaccines / Q000494:pharmacology; D008297:Male; D008970:Molecular Weight; D010455:Peptides / Q000627:therapeutic use*; D051381:Rats; D012485:Salmonella typhi / Q000276:immunology; D013950:Thymus Gland
D001428:Bacterial Vaccines; D007252:Influenza Vaccines; D010455:Peptides